𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

✍ Scribed by Jonathon F. Parkinson; Helen R. Wheeler; Adele Clarkson; Catriona A. McKenzie; Michael T. Biggs; Nicholas S. Little; Raymond J. Cook; Marinella Messina; Bruce G. Robinson; Kerrie L. McDonald

Publisher
Springer US
Year
2007
Tongue
English
Weight
317 KB
Volume
87
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The prognostic impact of O6-Methylguanin
The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma
✍ S. Baumann; G. Keller; F. PΓΌhringer; R. Napieralski; M. Feith; R. Langer; H. HΓΆf πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 87 KB

## Abstract Promotor hypermethylation is a common event in human cancer. __O^6^‐Methylguanine‐DNA Methyltransferase__ (__MGMT__) is a gene involved in DNA repair, which is methylated in a variety of cancer types. In colorectal cancer and lung cancer, hypermethylation of __MGMT__ has been correlated

O6-methylguanine-DNA methyltransferase g
O6-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation
✍ Christine Rolhion; FrΓ©dΓ©rique Penault-Llorca; Jean-Louis Kemeny; Fabrice Kwiatko πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 169 KB πŸ‘ 2 views

Repair of cytotoxic DNA damage by O 6 -methylguanine-DNA methyltransferase (MGMT) is a potentially important factor of chemoresistance to chloroethylnitrosoureas (CE-NUs), commonly used in the treatment of glioblastoma multiforme (GBM). The value of p53 as a prognostic factor in GBMs remains unclear